Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
4.050
+0.020 (0.50%)
Feb 24, 2026, 12:54 PM EST - Market open
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $228.68 million as of February 24, 2026. Its market cap has increased by 6.85% in one year.
Market Cap
228.68M
Enterprise Value
147.77M
1-Year Change
6.85%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $228.68M, an increase of 15.82%. That is a compound annual growth rate of 2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 23, 2026 | 227.55M | -2.89% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 234.50M |
| MediWound | 232.59M |
| Surrozen | 229.89M |
| Alector | 229.22M |
| Prelude Therapeutics | 228.24M |
| Nuvectis Pharma | 225.44M |
| Sol-Gel Technologies | 225.37M |
| Achieve Life Sciences | 224.65M |